This site is intended for healthcare professionals
Drug news

Full patient enrollment achieved in ILLUMINATE-A Phase III study of lumasiran to treat primary hyperoxaluria type 1

Read time: 1 mins
Last updated:19th Jun 2019
Published:18th Jun 2019
Source: Pharmawand
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest